Advertisement

Topics

Synergys Biotherapeutics Company Profile

02:52 EDT 18th June 2019 | BioPortfolio

Synergys is an early stage company developing multifunctional anti-vascularization antibody drugs targeting VEGF-alternative pathways. The Company’s most advanced product candidate, Anti-EGFR‐TAP (SYN001) was derived from its platform technology termed A‐TAP (Antibody-Targeted Anti-Vascularization Payload). SYN001 is currently in preclinical development for Triple Negative Breast Cancer (TNBC) and for other EGFR+ malignancies. Additionally, a second candidate, Anti-HER2-TAP (SYN002) is being developed for ovarian cancer. Synergys’ pipeline also includes a fully human bi-targeted anti-angiogenic antibody (Anti-Ang-1/2 Mab) with promising anti-tumor activities in colorectal and pancreatic cancer models. For more information contact: Dr. Rathin Das, CEO, Synergys Biotherapeutics, Ph: 925-575-0181; email: rathindas@synergysbio.com, and visit www.Synergysbio.com


News Articles [232 Associated News Articles listed on BioPortfolio]

Evotec to acquire biologics company Just Biotherapeutics

Evotec has entered a definitive agreement to acquire Just Biotherapeutics and its in-house drug development technology platform J.DESIGN. Just Biotherapeutics provides machine-learning...Read More.....

Evotec Pays $90 Million for Just Biotherapeutics

German drug discovery and development company Evotec has signed an agreement to buy Just Biotherapeutics, a US biologics company. Founded in 2014, Just Biotherapeutics is backed by investors that incl...

DGAP-Adhoc: Evotec SE akquiriert Just Biotherapeutics, Inc. (deutsch)

Evotec SE akquiriert Just Biotherapeutics, Inc. DGAP-Ad-hoc: Evotec SE / Schlagwort(e): Firmenübernahme Evotec SE akquiriert Just Biotherapeutics, Inc. 20.05.2019 / 22:24 CET/CEST Veröffentlichung ....

Iovance Biotherapeutics to build cell therapies plant in US

Iovance Biotherapeutics has announced plans to construct a commercial-scale production facility in Philadelphia, US. This 136,000ft2 plant will be used...Read More... The post Iovance Biotherapeutics ...

FDA fast-tracks Iovance Biotherapeutics' cervical cancer drug

Iovance Biotherapeutics' LN-145, which is in midstage development to treat patients with recurrent or metastatic cervical can -More- 

Evotec kauft Just Biotherapeutics für bis zu 81 Mio EUR

FRANKFURT (Dow Jones)--Evotec kauft in den USA zu. Für umgerechnet bis zu 81 Millionen Euro übernimmt das Unternehmen die in Seattle ansässige Just Biotherapeutics. Der Kaufpreis schließe eine pot...

Evotec To Buy Just Biotherapeutics For Up To US$90 Mln

HAMBURG (dpa-AFX) - Evotec SE (EVTCY.PK, EVOTF.PK) said that it agreed to acquire Just Biotherapeutics Inc. based in Seattle, WA, USA for up to US$90 million or about 81 million euros including po...

Stealth BioTherapeutics nets $72.5mm via IPO

Stealth BioTherapeutics Corp. (developing therapies for diseases involving mitochondrial dysfunction) netted $72.5mm through the initial public offering of 6.5mm American Depositary Shares (each ADS r...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Hepagam b [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use HepaGam B safely and effectively. See full prescribing information for HepaGam B. HepaGam B [Hepatitis B Immune Globulin Intravenous (...

Hepagam b [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use HepaGam B safely and effectively. See full prescribing information for HepaGam B. HepaGam B [Hepatitis B Immune Globulin Intravenous (...

Atryn [gtc biotherapeutics, inc.]

These highlights do not include all the information needed to use ATryn safely and effectively. See full prescribing information for ATryn. ATryn, Antithrombin (Recombinant) Lyophilized powder for rec...

Winrho [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use WinRho SDF safely and effectively. See full prescribing information for WinRho SDF. WinRho SDF [Rho(D) Immune Globulin Intravenous (Hu...

Ixinity [aptevo biotherapeutics llc]

These highlights do not include all the information needed to use IXINITY® safely and effectively. See full prescribing information for IXINITY.. IXINITY [coagulation factor IX (recombinant)] Lyophil...

PubMed Articles [17 Associated PubMed Articles listed on BioPortfolio]

Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc region.

The development of biotherapeutics requires continuous improvement in analytical methodologies for the assessment of their quality attributes. A subset of biotherapeutics is designed to interact with ...

Reliable LC-MS Multi-Attribute Method for Biotherapeutics by Run-Time Response Calibration.

A major challenge of a mass spectrometry-based quantitative multi-attribute method (MAM) for biotherapeutics is its high variability between instruments. For reproducible attribute measurements, not o...

Development and validation of a multiplexed drug level assay in support of combination biologics therapy clinical studies.

Clinical development of biotherapeutics for combination therapy requires monitoring the concentrations of both drugs in biological samples. Traditionally, two assays are required to measure drug level...

Chemoenzymatic synthesis of glycoproteins.

The majority of the world's best-selling biotherapeutics are glycoproteins. However their production using cellular expression systems invariably produces inseparable mixtures of materials which diffe...

Development of bacteria as diagnostics and therapeutics by genetic engineering.

Bacteria sense and respond to the environment, communicate, and continuously interact with their surroundings, including host bodies. For more than a century, engineers have been trying to harness the...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

The purpose of this study is to: - evaluate the safety profile of a single intravenous administration of AIGIV (containing either 3.5 mg/kg, 7.0 mg/kg or 14.0 mg/kg anti-PA IgG) a...

A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study

This is a Phase 2, randomized, double-blind, placebo-controlled crossover study which will enroll up to 36 subjects (anticipated) with genetically confirmed mitochondrial disease who have ...

The Effect of OASIS Ultra on Critical Sized Wound Healing

The aim of this study is to evaluate the speed and quality with which OASIS® Ultra (Healthpoint Biotherapeutics; Fort Worth, Texas) increases wound healing in the critical sized defect. ...

Personalized Immunotherapeutics for Antibiotic-resistant Infection

M. A. suffers from hypogammaglobulinemia that has been complicated by refractory Mycoplasma hominis septic arthritis. He has been receiving the antibiotic valnemulin under Emergency Invest...

Companies [107 Associated Companies listed on BioPortfolio]

Synergys Biotherapeutics

Synergys is an early stage company developing multifunctional anti-vascularization antibody drugs targeting VEGF-alternative pathways. The Company’s most advanced product can...

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and the central nervous system to develop a new class of biotherapeutics ...

EpimAb Biotherapeutics EpimAb Biotherapeutics

EpimAb Biotherapeutics is a privately-owned biopharmaceutical R&D company based in Shanghai with a proprietary and efficient technology called FIT-Ig® (Fabs-In-Tandem Immunogl...

Napro Biotherapeutics Incorporated

NaPro BioTherapeutics, Inc. is a natural product pharmaceutical company focused primarily on the development, manufacture and commercializa tion of paclitaxel, a naturally-occurring anti-cancer agent ...

Sephos Biotherapeutics

Sephos Biotherapeutics is a privately owned company focused on designing drugs for the treatment of cancer stem cells where the structure and biological activity of the drugs have...

More Information about "Synergys Biotherapeutics" on BioPortfolio

We have published hundreds of Synergys Biotherapeutics news stories on BioPortfolio along with dozens of Synergys Biotherapeutics Clinical Trials and PubMed Articles about Synergys Biotherapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synergys Biotherapeutics Companies in our database. You can also find out about relevant Synergys Biotherapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record